Imbruvica 420 MG tablet 28S
Ended Awarded
- Contract number
- SPE2DX25FVHCF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $22,727
Award facts
- Contract value 100% obligated
- $22,727.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,727.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count package), with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed from the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills pharmaceutical needs across multiple therapeutic domains for military and veteran healthcare systems through its established federal contracting relationships with the Defense Logistics Agency. This specific delivery order for Imbruvica, a specialty oncology medication, demonstrates the company's capability to supply brand-name pharmaceuticals and specialized medical commodities to support the Department of Defense medical supply chain. The award reflects AmerisourceBergen's competitive standing within the federal pharmaceutical procurement landscape and its role as a primary supplier within the broader DLA Pharmaceutical Prime Vendor program structure.
Quick answers
Who was awarded contract SPE2DX25FVHCF?
SPE2DX25FVHCF was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 18, 2025.
How much is contract SPE2DX25FVHCF worth?
The government has obligated $22,727 on SPE2DX25FVHCF.
Is contract SPE2DX25FVHCF an order under another contract?
Yes. SPE2DX25FVHCF is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVHCF competed?
The extent of competition for SPE2DX25FVHCF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award